Veerhealth Care Expands Vapi Facility for Growth in US and African Markets

Veerhealth Care has announced the acquisition of a land parcel near its Vapi factory in Gujarat as part of a Rs 33-crore expansion plan. This acquisition aims to establish new manufacturing lines compliant with US FDA norms to meet growing demands from the US, East, and North African markets.

On Thursday, Veerhealth Care revealed its acquisition of a land parcel near its Vapi factory in Gujarat, which is part of a Rs 33-crore expansion initiative.

This new land will enable the installation of manufacturing lines compliant with CGMP norms, essential to meet the rising demand from US, East, and North African markets, according to a company statement.

Veerhealth Care revealed that it had acquired 27,451 square feet of land, adjacent to its existing Vapi facility, bringing the total plot area to 58,623 square feet. The company plans to introduce high-capacity manufacturing lines to meet anticipated demand and achieve a revenue target of ₹100 crore over the next 2-3 years, with a focus on Ayurvedic herbal products.

(With inputs from agencies.)